ACHP (compound 4j) is a selective and orally active IkappaB kinase inhibitor with IC50 values of 8.5 nM and 250 nM for IKKbeta and IKKalpha, respectively. ACHP can effectively inhibit the STAT3 signaling pathway and induce cancer cell cycle arrest and apoptosis. ACHP shows anti-inflammatory activity in a mouse ear edema model. ACHP can be used in anti-inflammatory and anti-cancer (such as multiple myeloma and leukemia) studies[1][2][3][4].
Molekulargewicht:
364.44
CAS Nummer:
[406208-42-2]
Formel:
C21H24N4O2
Target-Kategorie:
Apoptosis,IKK,STAT
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
